Welcure Drugs and Pharmaceuticals Limited

₹0.20As of Sun 8 Nov 2026, 12:00 UTC
BSE:524661Healthcare
Country India
PE (Fwd) •••
TSR 10Y CAGR (2.92%)
Div yield —
ROE (5.50%)
Pharmaceutical Preparations
Beta (5Y) (0.31)
PE TTM —
TSR TTM (63.64%)
Mkt cap ₹247.2M
ROIC (3.10%)
SE Grade™
Value
Quality
Moat
Consensus
Reference
₹0.22
10.09%
(67.35%)
Hold 2|8|9|1|3
3Q26
4Q26
1Q27
2Q27
Earnings per share₹
—
—
—
—
(2.38%)
10.16%
10.31%
2.55%
Revenue₹M
14.90
15.00
14.95
14.97
9.53%
6.81%
8.10%
5.96%
Peers (US$2.369M)
Cap (US$)
PE
3.016M
11.78x
2.435M
9.419x
2.366M
—
Capital
TTM
5Y
10Y
Leveragex
0.975
0.021
0.019
EBIT/Intx
0.919
0.260
0.263
Own earn%
48.95
26.26
9.68
Sh yield%
39.41
25.57
25.17
Owners
Insiders/Inst%
11.69
29.51
Short interest%
1.87
SBC / revenue%
5.47
Record
10Y
Profitable years
10/10
Revenue growth years
10/10
EPS growth years
10/10
Dividend streakyrs
23
Op margin range%
19–27
$1 testx
−0.1
Incr. ROIC%
8